Ettinger, S. and Jeindl, R. (2023): Cipaglucosidase alfa (Pombiliti®) in combination with Miglustat for the treatment of adults with late-onset Pompe disease (acid α‑glucosidase [GAA] deficiency). Fact Sheet Nr. 124.

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Fischer, S. and Zechmeister-Koss, I. and Huic, M. (2013): Duodeno-jejunal bypass liner (DJBL) for patients with obesity, with/without type 2 diabetes mellitus . Decision Support Document 67.

Gassner, L. and Reinsperger, I. (2021): National strategies and programmes for preventing and managing non-communicable diseases in selected countries. HTA-Projektbericht 139.

Goetz, G. and Hofer, V. and Jeindl, R. and Walter, M. (2022): Telemonitoring in Austrian diabetes care: A systematic analysis of evaluation methodologies. HTA-Projektbericht 143.

Goetz, G. and Walter, M. and Wohlhöfner, K. and Wittenberg, H. and Saal, S. and Stephan, K.M. and Dohle, C. (2021): Robotics and functional electrical stimulation for stroke rehabilitation. HTA-Projektbericht 128.

Radlberger, P. (2007): [Mass spectrometry for metabolic diseases in newborns]. HTA-Newsletter 60: pp. 3-4.

Semlitsch, T. and Horvath, K. (2019): Screening for Diabetes mellitus: guideline recommendations. HTA-Projektbericht 118.

Walter, M. and Gassner, L. (2021): Liposuction for surgical therapy of lipoedema. Decision Support Document 125.

Walter, M. and Strohmaier, C. (2020): Genetic Testing in the Context of Familial Hypercholesterolaemia Management. HTA-Projektbericht 130.

Wild, C. (2005): [Statins for acute coronary syndrome]. HTA-Newsletter 42: pp. 3-4.

Wild, C. (2005): [Surgery for morbid obesity]. HTA-Newsletter 42: p. 2.

Wild, C. (2003): [Extracorporeal immunoadsorption treatment]. HTA-Newsletter 19: pp. 2-3.

Wild, C. (2003): [Interventions for preventing obesity in children and adolescents]. HTA-Newsletter 16: pp. 2-3.

Wild, C. (2002): [Tandem mass spectometry (TMS) and neonatal screening]. HTA-Newsletter 10: pp. 3-4.

Wild, C. (2002): [Drug therapy for adiposity]. HTA-Newsletter 08: pp. 3-4.

Wild, C. (2002): [Surgical treatment of obesity]. HTA-Newsletter 08: p. 4.

Wolf, S. and Kern, J. (2024): Strategies for reducing weight stigmatisation towards people with overweight or obesity in the healthcare system. HTA-Projektbericht 160.

Zechmeister, I. (2006): [Statins: Economic evaluation]. HTA-Newsletter 48: p. 2.

Zechmeister, I. and Mathis, S. and Guba, B. and Gartlehner, G. (2008): [LDL apheresis. Systematic review]. Decision Support Document 07.

Zechmeister, I. and Wild, C. (2006): [Statins and their prognosed as well as real impact on hospital services in Austria]. ITA-Projektbericht 30.

Zechmeister, I. (2006): [Cost-effectiveness of statins]. ITA-Newsletter March 2006: p. 3.